On one cold afternoon in 2018, chemists in a Canberra festival tent told a man his "meth" was a different drug, one that had caused mass overdoses in New Zealand. His dealer hadn't known, or hadn't said. Nobody required the dealer to know. Think about what that means. He was the lucky one. Everyone else that day bought from the same kind of seller and never found out.
Festival lights, out of focus. So is what's in the pill.
A tent in the rain
On Sunday 29 April 2018, the Groovin the Moo festival ran on the University of Canberra campus. In one corner stood a tent three metres by six. Inside were chemists with an infrared spectrometer, a doctor, and peer workers. It was Australia's first legally sanctioned pill-testing service, and the people who ran it paid for it themselves (Makkai et al., 2018).
It rained. The temperature dropped to 2.9 degrees. Over twelve hours, 125 people walked up to be assessed and 85 samples went into the machine (Makkai et al., 2018).
One man, in his late thirties, had bought a powder from his usual dealer. The dealer called it "meth". The machine said N-ethylpentylone, a synthetic cathinone that had caused mass-casualty overdoses in New Zealand. The report says he was "somewhat surprised" (Makkai et al., 2018, p. 23).
The seller who checks nothing
We say we ban drugs to protect people, and everyone wants that: children kept away, adults kept alive. So look at what the ban actually does. A bottle shop checks your age. A pharmacy prints the dose on the box and asks what else you take. A pharmacist who misses an interaction answers to a board, and a company that mislabels a product recalls it.
A dealer does none of that. There's no licence to lose, so there's no reason to check an age. There's no label, so there's no dose. There's no recall. When drugs are illegal, every rule that protects buyers of every other product disappears, because the only seller left can't be held to any of them. Age limits work where a seller has something to lose. A dealer loses nothing by selling to a fifteen-year-old.
The Canberra tent wasn't unusual. At the first UK festival testing service in 2016, chemists checked 247 samples and found one in five wasn't what the buyer had been told (Measham, 2019). These aren't bad batches. They're what an unregulated market produces on an ordinary day.
Three more things the law takes away
It rewards strength. A smuggler carries risk per kilogram, so the profitable product is the most potent one. Alcohol prohibition moved American drinkers from beer to spirits; the drug laws moved opium smokers to heroin and now heroin users to fentanyl. Richard Cowan called it the iron law of prohibition (Cowan, 1986). And it hasn't made drugs scarce. US prices of heroin, cocaine and cannabis, adjusted for purity and inflation, fell by more than 80% between 1990 and 2007 (Werb et al., 2013).
It makes people afraid of the ambulance. People who fear arrest use alone and wait to call for help. In the United States, laws giving bystanders access to naloxone were followed by 9% to 11% fewer opioid deaths (Rees et al., 2019).
It hides the margin. The gap between a usual dose and a lethal one is about 6 for injected heroin, 10 for alcohol and 16 for MDMA, and about 1,000 for LSD and psilocybin (Gable, 2004). With no dose on the packet, the buyer is guessing at exactly the number that matters most.
How the schedules were made
Nobody drew the drug laws up from pharmacology. John Ehrlichman, Richard Nixon's domestic policy adviser, told the journalist Dan Baum in 1994 that the White House had two enemies, the antiwar left and Black people. "We knew we couldn't make it illegal to be either against the war or black, but by getting the public to associate the hippies with marijuana and blacks with heroin, and then criminalizing both heavily, we could disrupt those communities... Did we know we were lying about the drugs? Of course we did" (Baum, 2016). Other Nixon aides disowned the remark when it came out. Australia's first federal drug law, in 1905, banned opium for smoking, a practice tied to Chinese Australians, while opium in patent medicines sold to everyone else stayed legal (Manderson, 1993).
When an expert panel scored 20 drugs on 16 kinds of harm, alcohol came first, ahead of heroin and crack (Nutt et al., 2010). Alcohol is sold beside the milk. A list drawn up by risk wouldn't look like that. A list drawn up by who used what, a century ago, would.
One molecule, two legal lives
Gamma-hydroxybutyrate (GHB) shows it in one compound. Illicit GHB sits in Schedule I in the United States. The same molecule, as the prescription drug sodium oxybate, sits in Schedule III. A review of the two forms found the risks of the illicit one are greater, and gave the reasons: differences in "accessibility, purity, dosing" and a controlled channel of supply (Carter et al., 2009). Same molecule. The supply decides the harm.
What people do when they know
Telling people what they hold changes what they do. In Canberra, after their results, 18% said they wouldn't take illicit drugs that day, 12% said they would take less, and 8% said they would throw the drug away (Makkai et al., 2018). In the UK, one in five people handed in further substances, and two-thirds of those whose drug had been missold got rid of more (Measham, 2019).
When Canberra opened a permanent clinic, CanTEST, in 2022, about one sample in ten went in the bin after testing, and when a drug wasn't what they expected, about one client in three said they wouldn't take it (Australian National University, 2023). Nobody in those rooms was told drugs are fine. They were told the truth about one pill. That's all a label does.
After Vancouver's Insite opened in 2003, fatal overdoses within 500 metres fell 35.0%, against 9.3% in the rest of the city (Marshall et al., 2011). None of it depends on approving of drug use. Each puts back a piece of what a legal market would supply anyway: clean equipment, a known dose, a witness, an antidote, a label.
Six deaths and an inquest
Between December 2017 and January 2019, six young people aged 18 to 23 died after taking MDMA at New South Wales music festivals. In November 2019, Deputy State Coroner Harriet Grahame made 28 recommendations. They included a drug-checking trial, an end to drug dogs at festivals, and serious consideration of decriminalising personal use (State Coroner's Court of New South Wales, 2019).
The state government restated its opposition to pill testing. Five years and a drug summit later, it announced a 12-month trial at festivals from 2025 (Australian Associated Press, 2024).
A country that stopped punishing users
Portugal tried the bigger version. On 1 July 2001 it made possessing up to ten days' supply of any drug an administrative matter, not a crime. People found with drugs go before a panel of a lawyer, a social worker and a health professional, which can send them to treatment, fine them or do nothing. Supply stayed a crime, and treatment was funded. Drug deaths fell from about 80 in 2001 to 16 in 2012, a fall of about 80%, and new HIV diagnoses among people who inject drugs fell from 1,016 to 56 (Murkin, 2014). The predicted surge in use didn't come (Hughes & Stevens, 2010). The gains weren't only the law: treatment got funded too. That's the point. The criminal route and the health route compete for the same people, and removing the first lets the second reach them (Hughes & Stevens, 2012).
Twenty years on, the WHO's mortality records for 2011 to 2019 show Portugal at 3.6 drug deaths per million people a year, against 12.5 for the middle country in Europe. Its count has crept up since, and the law alone can't take the credit: some strict Eastern European countries also record low rates. But the catastrophe everyone predicted never came (World Health Organization, 2026).
Oregon is the objection people raise. It decriminalised possession in February 2021, just as fentanyl swept its market, and deaths rose. Once the spread of fentanyl is accounted for, the link to the law changes sign and is no longer significant (Zoorob et al., 2024). Decriminalising possession while the dealer still controls the contents leaves the dealer in charge, which is this argument.
Where Australia's money goes
In 2021/22 Australian governments spent about $5.45 billion on illicit drugs. Law enforcement took 64.3%. Harm reduction, the testing tents, clean needles and overdose-reversal drugs, got 1.6% (Ritter et al., 2024). The things most likely to keep someone's kid alive get the smallest share.
What replaces prohibition
Regulate in proportion to risk (Transform Drug Policy Foundation, 2020). Licensed adult shops, ID checks and tested, labelled products for cannabis. Pharmacy or service-centre access with dose information for MDMA, psilocybin and LSD. Pharmacy supply with screening and dose limits for cocaine and amphetamines. Prescription and supervision for heroin and strong opioids, as Switzerland has done since 1994 (Rehm et al., 2001). Around all of it: no criminal record for possession, testing wherever drugs get used, naloxone, protection for whoever calls for help, and treatment on request. Violence, impaired driving and neglecting a child stay offences, sober or not. Punish what people do to others.
The evidence is mostly observational, and no country has yet regulated every drug. Nobody can promise exact numbers. But prohibition's own results have had more than a century to come in.
What you can do
Life sucks more than it has to for a mother waiting at a hospital because of a dose nobody could read. That part we can change.
If you or someone you love uses opioids, or anything that might contain them, get naloxone. Australia's Take Home Naloxone program gives it out free. Ask a pharmacy or your local health service. Call 000 if anyone goes down; a life comes first. Ask whether a drug-checking service runs near you, and use it. And if your state has dropped or hasn't started testing, write to the health minister with one question: the coroner asked for this in 2019, so what evidence says no?
Go back to the tent in the rain. A man found out what he held because, for one afternoon, someone let chemists stand between him and the market. Print the dose on the packet, and every afternoon could be like that.
Test the pill. Then go back to the music.
Sources
- Australian Associated Press. (2024, December 19). 'Reduce harm and save lives': Pill testing trial to go ahead at NSW music festivals. SBS News. https://www.sbs.com.au/news/article/reduce-harm-and-save-lives-pill-testing-trial-to-go-ahead-at-nsw-music-festivals/b4vvilo09
- Australian National University. (2023). Canberra pill testing clinic 'changing peoples' drug behaviours', evaluation finds. anu.edu.au
- Baum, D. (2016, April). Legalize it all: How to win the war on drugs. Harper's Magazine. https://harpers.org/archive/2016/04/legalize-it-all/
- Carter, L. P., Pardi, D., Gorsline, J., & Griffiths, R. R. (2009). Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): Differences in characteristics and misuse. Drug and Alcohol Dependence, 104(1–2), 1–10. https://doi.org/10.1016/j.drugalcdep.2009.04.012
- Cowan, R. (1986). How the narcs created crack. National Review, 38(23), 26–31.
- Gable, R. S. (2004). Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction, 99(6), 686–696. https://doi.org/10.1111/j.1360-0443.2004.00744.x
- Hughes, C. E., & Stevens, A. (2010). What can we learn from the Portuguese decriminalization of illicit drugs? British Journal of Criminology, 50(6), 999–1022. https://doi.org/10.1093/bjc/azq038
- Hughes, C. E., & Stevens, A. (2012). A resounding success or a disastrous failure: Re-examining the interpretation of evidence on the Portuguese decriminalisation of illicit drugs. Drug and Alcohol Review, 31(1), 101–113. https://doi.org/10.1111/j.1465-3362.2011.00383.x
- Makkai, T., Macleod, M., Vumbaca, G., Hill, P., Caldicott, D., Noffs, M., Tzanetis, S., & Hansen, F. (2018). Report on the ACT GTM pill testing pilot: A harm reduction service. Harm Reduction Australia. https://www.drugsandalcohol.ie/29513/1/Pill-Testing-Pilot-ACT-June-2018.pdf
- Manderson, D. (1993). From Mr Sin to Mr Big: A history of Australian drug laws. Oxford University Press.
- Marshall, B. D. L., Milloy, M.-J., Wood, E., Montaner, J. S. G., & Kerr, T. (2011). Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: A retrospective population-based study. The Lancet, 377(9775), 1429–1437. https://doi.org/10.1016/S0140-6736(10)62353-7
- Measham, F. C. (2019). Drug safety testing, disposals and dealing in an English field: Exploring the operational and behavioural outcomes of the UK's first onsite 'drug checking' service. International Journal of Drug Policy, 67, 102–107. https://doi.org/10.1016/j.drugpo.2018.11.001
- Murkin, G. (2014). Drug decriminalisation in Portugal: Setting the record straight. Transform Drug Policy Foundation. https://www.unodc.org/documents/ungass2016/Contributions/Civil/Transform-Drug-Policy-Foundation/Drug-decriminalisation-in-Portugal.pdf
- Nutt, D. J., King, L. A., & Phillips, L. D. (2010). Drug harms in the UK: A multicriteria decision analysis. The Lancet, 376(9752), 1558–1565. https://doi.org/10.1016/S0140-6736(10)61462-6
- Rees, D. I., Sabia, J. J., Argys, L. M., Dave, D., & Latshaw, J. (2019). With a little help from my friends: The effects of Good Samaritan and naloxone access laws on opioid-related deaths. The Journal of Law and Economics, 62(1), 1–27. https://doi.org/10.1086/700703
- Rehm, J., Gschwend, P., Steffen, T., Gutzwiller, F., Dobler-Mikola, A., & Uchtenhagen, A. (2001). Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: A follow-up study. The Lancet, 358(9291), 1417–1423. https://doi.org/10.1016/S0140-6736(01)06529-1
- Ritter, A., Grealy, M., Kelaita, P., & Kowalski, M. (2024). The Australian 'drug budget': Government drug policy expenditure 2021/22 (DPMP Monograph No. 36). Drug Policy Modelling Program, UNSW Sydney.
- State Coroner's Court of New South Wales. (2019). Inquest into the death of six patrons of NSW music festivals: Findings of Deputy State Coroner Harriet Grahame.
- Transform Drug Policy Foundation. (2020). How to regulate stimulants: A practical guide. Transform Drug Policy Foundation.
- Werb, D., Kerr, T., Nosyk, B., Strathdee, S., Montaner, J., & Wood, E. (2013). The temporal relationship between drug supply indicators: An audit of international government surveillance systems. BMJ Open, 3(9), e003077. https://doi.org/10.1136/bmjopen-2013-003077
- World Health Organization. (2026). WHO mortality database: Raw data files [Data set]. https://www.who.int/data/data-collection-tools/who-mortality-database
- Zoorob, M. J., Park, J. N., Kral, A. H., Lambdin, B. H., & del Pozo, B. (2024). Drug decriminalization, fentanyl, and fatal overdoses in Oregon. JAMA Network Open, 7(9), e2431612. https://doi.org/10.1001/jamanetworkopen.2024.31612